Article Text
Therapeutics/Prevention
Randomised controlled trial
LABA/LAMA combinations instead of LABA/ICS combinations may prevent or delay exacerbations of COPD in some patients
Statistics from Altmetric.com
Footnotes
Competing interests MC is a consultant and a member of the Speaker Bureau at Novartis.
Provenance and peer review Commissioned; internally peer reviewed.